title: Sudden hearing loss and autoimmune inner ear disease.
abstract: This case report describes the audiologic and medical diagnostic evaluations, results, and treatment options in a patient with a classic presentation of immune-mediated sensorineural hearing loss, commonly called autoimmune inner ear disease (AIED). It reviews findings of the basic battery, immittance audiometry, transient otoacoustic emissions, and auditory brainstem response measures and medical findings over more than 2 years. AIED generally causes asymmetric bilateral sensorineural hearing loss with atypical configuration. Although hearing loss is generally fluctuant, the overall pattern is usually rapid progression, particularly in the absence of early medical intervention. Word recognition is usually disproportionately poor. In our case, otoacoustic emissions and auditory brainstem responses suggest both cochlear and retrocochlear involvement and may initially appear to be inconsistent with pure-tone thresholds. Audiologists must be familiar with AIED because early identification is critical. Additionally, an immunologic basis may be a factor in other disorders, including many cases of Meniere's disease.
authors.affiliation: Department of Surgery, Southern Illinois University School of Medicine, Springfield, USA.
authors.forename: K C
authors.initials: KC
authors.lastname: Campbell
authors.forename: J J
authors.initials: JJ
authors.lastname: Klemens
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001301:Audiometry, Pure-Tone / Q000379:methods; D001309:Auditory Threshold / Q000502:physiology; D001327:Autoimmune Diseases / Q000150:complications*; D004427:Ear Diseases / Q000150:complications*; D005072:Evoked Potentials, Auditory / Q000502:physiology; D016057:Evoked Potentials, Auditory, Brain Stem; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003639:Hearing Loss, Sudden / Q000209:etiology; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D017084:Otoacoustic Emissions, Spontaneous / Q000502:physiology; D012720:Severity of Illness Index
chemical_list: D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone